Leucine-rich repeat–containing protein 15 (LRRC15) is a cell surface protein that has emerged as a significant biomarker in cancer biology. This protein is minimally expressed in normal healthy tissue ...

RECIST was developed in 2000 by the National Cancer Institute, European Organization for Research and Treatment of Cancer, and National Cancer Institute of Canada, with revision to RECIST 1.1 in 2009 ...

Dr. Bernd Pichler is a distinguished pioneer in preclinical and translational imaging, renowned for his groundbreaking work ...

Journal of Nuclear Medicine October 2025, jnumed.125.270239; DOI: https://doi.org/10.2967/jnumed.125.270239 ...

Large language models have become enormously powerful tools for summarizing existing knowledge and generating text, figures, and references for scientific publications. This power can be abused to ...

Journal of Nuclear Medicine October 2025, jnumed.125.270414; DOI: https://doi.org/10.2967/jnumed.125.270414 ...

Journal of Nuclear Medicine August 2025, jnumed.124.269234; DOI: https://doi.org/10.2967/jnumed.124.269234 ...

Journal of Nuclear Medicine June 2025, jnumed.124.269273; DOI: https://doi.org/10.2967/jnumed.124.269273 ...

Journal of Nuclear Medicine June 2025, 66 (supplement 1) 252173; ...

TO THE EDITOR: In the published VISION trial results on 177Lu-vipivotide tetraxetan (Pluvicto; Novartis) use in metastatic castration-resistant prostate cancer, the mass and molar activity of prostate ...

Journal of Nuclear Medicine April 2025, jnumed.124.268980; DOI: https://doi.org/10.2967/jnumed.124.268980 ...

Journal of Nuclear Medicine March 2025, jnumed.124.269299; DOI: https://doi.org/10.2967/jnumed.124.269299 ...